Trials / Sponsors / NextPoint Therapeutics, Inc.
NextPoint Therapeutics, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2 Metastatic Malignant Neoplasm | Phase 1 | 2024-01-22 |
| Suspended | A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7 Metastatic Malignant Neoplasm | Phase 1 | 2023-07-21 |